| Identification | Back Directory | [Name]
(R)-6-Benzyloxy-8-(oxiran-2-yl)-4H-benzo[1,4]oxazin-3-one | [CAS]
869478-12-6 | [Synonyms]
6-benzyloxy-(8R)-oxiranyl-4H-benzo[1,4]oxazin-3-one
(R)-6-Benzyloxy-8-(oxiran-2-yl)-4H-benzo[1,4]oxazin-3-one
8-(2R)-Oxiranyl-6-(phenylmethoxy)-2H-1,4-benzoxazin-3(4H)-one
2H-1,4-Benzoxazin-3(4H)-one, 8-[(2R)-2-oxiranyl]-6-(phenylmethoxy)-
(R) -6-benzoxy-8 - (ethylene oxide - 2-yl) -4H- benzo [1,4] oxazine - 3-1
(R)-6-(Benzyloxy)-8-(oxiran-2-yl)-2H-benzo[b][1,4]oxazin-3(4H)-one (R)-6-(Benzyloxy)-8-(oxiran-2-yl)-2H-benzo[b][1,4]oxazin-3(4H)-one | [EINECS(EC#)]
925-223-9 | [Molecular Formula]
C17H15NO4 | [MDL Number]
MFCD30729959 | [MOL File]
869478-12-6.mol | [Molecular Weight]
297.31 |
| Hazard Information | Back Directory | [Uses]
(R)-6-Benzyloxy-8-(oxiran-2-yl)-4H-benzo[1,4]oxazin-3-one is an intermediate in the synthesis of Olodaterol (O262000), a novel inhaled β2-adrenoceptor agonist with a 24h bronchodilatory efficacy. |
|
|